Gingko biloba extract (EGb 761) prevents cerebral ischemia-induced p70S6 kinase and S6 phosphorylation

The American Journal of Chinese Medicine
Phil-Ok Koh

Abstract

EGb 761 is an extract of Gingko biloba that exhibits neuroprotective effects against cerebral ischemia. The mammalian target of rapamycin (mTOR) is a critical downstream effector of Akt and a central regulator of ribosomal biogenesis and protein synthesis. We investigated whether EGb 761 regulates Akt downstream targets, including mTOR, p70S6 kinase, and S6 phosphorylation. Adult male rats were treated with vehicle or EGb 761 (100 mg/kg) prior to middle cerebral artery occlusion (MCAO). Brains were collected at 24 hours after MCAO and the cerebral cortex regions were examined. We previously showed that EGb 761 significantly reduces infarct volume and decreases the number of TUNEL-positive cells in the cerebral cortex. Ischemic brain injury induces a decrease in Akt up-stream target, PDK1 phosphorylation. The levels of phospho-mTOR, phospho-p70S6 kinase, and phospho-S6 are subsequently decreased in regions affected by ischemic injury. However, EGb 761 prevented injury-induced decreases in these protein levels. We confirmed that EGb 761 inhibits injury-induced decreases in the number of positive cells for phospho-p70S6 kinase and phospho-S6. The results of this study provide evidence that EGb 761 protects neuronal cells against i...Continue Reading

References

Jan 1, 1992·Current Topics in Cellular Regulation·C G Proud
Jan 1, 1989·Stroke; a Journal of Cerebral Circulation·E Z LongaR Cummins
May 1, 1988·Pharmacological Research Communications·H OberpichlerJ Krieglstein
Apr 1, 1994·Molecular Neurobiology·L La Grenade
Jun 23, 1997·FEBS Letters·N Pullen, G Thomas
Dec 2, 1999·Experimental Cell Research·A Dufner, G Thomas
Dec 2, 1999·Genes & Development·S R DattaM E Greenberg
Jul 11, 2000·The European Journal of Neuroscience·S BastianettoR Quirion
Feb 13, 2001·Neurobiology of Disease·S JanelidzeB K Siesjö
Sep 29, 2001·Progress in Molecular and Subcellular Biology·A C GingrasN Sonenberg
Nov 2, 2001·Trends in Molecular Medicine·P K Vogt
Sep 12, 2003·Journal of Molecular and Cellular Cardiology·Adrienn KisGary F Baxter
Mar 23, 2005·Current Opinion in Cell Biology·James R Woodgett
May 15, 2007·Cellular and Molecular Life Sciences : CMLS·A KoltermannS Zahler
May 1, 1974·Gut·O JamesS Sherlock
Jul 17, 2009·The American Journal of Chinese Medicine·Jae-Hyeon ChoPhil-Ok Koh
May 5, 2011·Frontiers in Neuroscience·Y-F TanJ M Wojtowicz

❮ Previous
Next ❯

Citations

Mar 8, 2016·Medicines·Chong-Zhi WangChun-Su Yuan
Aug 30, 2011·BMB Reports·Seo-Kyoung Hwang, Hyung-Hwan Kim
Jun 26, 2013·Topics in Companion Animal Medicine·Michael E Peterson
Nov 26, 2015·Integrative Medicine Insights·Kevin M Nash, Zahoor A Shah
Jun 22, 2019·Current Vascular Pharmacology·Xiaoxue LiHui Huang
Jul 24, 2013·International Journal of Molecular Medicine·Hongwei ZhangTianpen Cui
Jan 25, 2017·Evidence-based Complementary and Alternative Medicine : ECAM·Dennis ChangAlan Bensoussan
Sep 9, 2019·Lancet Neurology·Longfei JiaUNKNOWN Group for the Project of Dementia Situation in China

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.